YI4 The Year in Obesity

Program: Endocrine "Year In" Sessions
Clinical Session
Monday, April 4, 2016: 10:00 AM-11:00 AM
BR West (BCEC)
Speaker:
Daniel H. Bessesen, MD, University of Colorado School of Medicine, Anschutz Medical Campus, Denver, CO

Disclosures:
DHB: data safety monitoring board, Enteromedics Inc.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire